These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1324047)

  • 1. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril.
    Linz W; Schölkens BA
    Br J Pharmacol; 1992 Apr; 105(4):771-2. PubMed ID: 1324047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of the enzyme of conversion and cardioprotection: role of bradykinins].
    Unger T; Lebrun CJ
    Diabete Metab; 1992; 18(2 Pt 2):161-9. PubMed ID: 1322327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril.
    Bao G; Gohlke P; Qadri F; Unger T
    Hypertension; 1992 Jul; 20(1):74-9. PubMed ID: 1319960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril.
    Rhaleb NE; Yang XP; Scicli AG; Carretero OA
    Hypertension; 1994 Jun; 23(6 Pt 2):865-8. PubMed ID: 7515854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis.
    Linz W; Wiemer G; Schaper J; Zimmermann R; Nagasawa K; Gohlke P; Unger T; Schölkens BA
    Mol Cell Biochem; 1995 Jun 7-21; 147(1-2):89-97. PubMed ID: 7494560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective actions of bradykinin in myocardial ischemia and left ventricular hypertrophy.
    Linz W; Wiemer G; Schölkens BA
    Braz J Med Biol Res; 1994 Aug; 27(8):1949-54. PubMed ID: 7749386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ACE inhibitor on DOCA-salt- and aortic coarctation-induced hypertension in mice: do kinin B2 receptors play a role?
    Rhaleb NE; Peng H; Alfie ME; Shesely EG; Carretero OA
    Hypertension; 1999 Jan; 33(1 Pt 2):329-34. PubMed ID: 9931125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
    Gohlke P; Lamberty V; Kuwer I; Bartenbach S; Schnell A; Linz W; Schölkens BA; Wiemer G; Unger T
    Hypertension; 1993 Nov; 22(5):682-7. PubMed ID: 8225528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.
    Gohlke P; Linz W; Schölkens BA; Kuwer I; Bartenbach S; Schnell A; Unger T
    Hypertension; 1994 Apr; 23(4):411-8. PubMed ID: 8144208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats.
    Gohlke P; Kuwer I; Schnell A; Amann K; Mall G; Unger T
    Hypertension; 1997 Jan; 29(1 Pt 2):478-82. PubMed ID: 9039145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor.
    Rossi GP; Cavallin M; Rizzoni D; Bova S; Mazzocchi G; Agabiti-Rosei E; Nussdorfer GG; Pessina AC
    J Hypertens; 2002 Jul; 20(7):1451-9. PubMed ID: 12131544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resetting blood pressure in spontaneously hypertensive rats. The role of bradykinin.
    O'Sullivan JB; Harrap SB
    Hypertension; 1995 Feb; 25(2):162-5. PubMed ID: 7843764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats.
    Amann K; Gassmann P; Buzello M; Orth SR; Törnig J; Gross ML; Magener A; Mall G; Ritz E
    Kidney Int; 2000 Jul; 58(1):153-61. PubMed ID: 10886560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models.
    Bao G; Gohlke P; Unger T
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S96-9. PubMed ID: 1282637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.
    Linz W; Schölkens BA; Ganten D
    Clin Exp Hypertens A; 1989; 11(7):1325-50. PubMed ID: 2530011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
    Linz W; Schölkens BA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
    Gohlke P; Linz W; Schölkens B; Van Even P; Martorana P; Unger T
    Br J Clin Pract Suppl; 1996 Jul; 84():1-10. PubMed ID: 8994995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats.
    Linz W; Schaper J; Wiemer G; Albus U; Schölkens BA
    Br J Pharmacol; 1992 Dec; 107(4):970-5. PubMed ID: 1334756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.
    Linz W; Schölkens BA; Kaiser J; Just M; Qi BY; Albus U; Petry P
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):873-82. PubMed ID: 2535056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinins mediate the antiproliferative effect of ramipril in rat carotid artery.
    Farhy RD; Ho KL; Carretero OA; Scicli AG
    Biochem Biophys Res Commun; 1992 Jan; 182(1):283-8. PubMed ID: 1531013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.